Similar articles

• Treatment of Pseudomonas aeruginosa biofilms with a combination of fluoroquinolones and fosfomycin in a rat urinary tract infection model.

  Mikuniya T, Kato Y, Ida T, Maebashi K, Monden K, Kariyama R, Kumon H. Mikuniya T, et al. J Infect Chemother. 2007 Oct;13(5):285-90. doi: 10.1007/s10156-007-0534-7. Epub 2007 Oct 30. J Infect Chemother. 2007. PMID: 17982715
• Aminoglycoside resistance emerging during therapy.

  Mawer SL, Greenwood D. Mawer SL, et al. Lancet. 1977 Apr 2;1(8014):749-50. doi: 10.1016/s0140-6736(77)92192-4. Lancet. 1977. PMID: 66540 No abstract available.
• [Antibiotic resistance and biofilm formation in Pseudomonas aeruginosa strains isolated from patients with urinary tract infections].

  Cernohorská L, Sláviková P. Cernohorská L, et al. Epidemiol Mikrobiol Imunol. 2009 Nov;58(4):154-7. Epidemiol Mikrobiol Imunol. 2009. PMID: 21114003 Czech.
• [Pseudomonas aeruginosa: Pathogenicity and antimicrobial resistance in urinary tract infection].

  Paz-Zarza VM, Mangwani-Mordani S, Martínez-Maldonado A, Álvarez-Hernández D, Solano-Gálvez SG, Vázquez-López R. Paz-Zarza VM, et al. Rev Chilena Infectol. 2019 Apr;36(2):180-189. doi: 10.4067/S0716-10182019000200180. Rev Chilena Infectol. 2019. PMID: 31344154 Review. Spanish.
• [Urinary tract infections].

  Arakawa S. Arakawa S. Nihon Rinsho. 2002 Nov;60(11):2200-3. Nihon Rinsho. 2002. PMID: 12440130 Review. Japanese.